Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. [electronic resource] by
- Blyth, Emily
- Clancy, Leighton
- Simms, Renee
- Ma, Chun K K
- Burgess, Jane
- Deo, Shivashni
- Byth, Karen
- Dubosq, Ming-Celine
- Shaw, Peter J
- Micklethwaite, Kenneth P
- Gottlieb, David J
Producer: 20130704
In:
Blood vol. 121
Availability: No items available.
|
|
9.
|
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells. [electronic resource] by
- Withers, Barbara
- Blyth, Emily
- Clancy, Leighton E
- Yong, Agnes
- Fraser, Chris
- Burgess, Jane
- Simms, Renee
- Brown, Rebecca
- Kliman, David
- Dubosq, Ming-Celine
- Bishop, David
- Sutrave, Gaurav
- Ma, Chun Kei Kris
- Shaw, Peter J
- Micklethwaite, Kenneth P
- Gottlieb, David J
Publication details: Blood advances Nov 2017
In:
Blood advances vol. 1
Availability: No items available.
|